Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:26 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 289–312 of 385 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Hip Arthrosis Clear all

Conditions: Osteoarthritis, Blood Loss, Surgical, Blood Loss, Postoperative
Interventions: Tranexamic Acid (Oral), Tranexamic Acid (Intravenous); Drug
Lead sponsor: The New England Baptist Hospital; Other
Eligibility: 18 Years and older
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Non-inflammatory Joint Diseases
Interventions: Total hip replacement; Device
Lead sponsor: DePuy Orthopaedics; Industry
Eligibility: 20 Years to 75 Years
Enrollment: 392 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 8
States / cities: Little Rock, Arkansas • Orange, California • Palm Bay, Florida + 5 more

Conditions: Knee Osteoarthritis, Hip Osteoarthritis
Interventions: Knotless suture for wound closure, Layered traditional wound closure (monocryl); Device
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Arthritis
Interventions: Total hip replacement; Procedure
Lead sponsor: Tennessee Orthopedic Alliance; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Newborn, Hip Dysplasia
Interventions: Hip Ultrasound; Diagnostic Test
Lead sponsor: University of California, San Francisco; Other
Eligibility: Up to 6 Weeks
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Fresno, California

Conditions: Hip Osteoarthritis, Arthroplasty, Replacement, Hip
Interventions: Educational program to address patients' expectations; Behavioral
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 55 Years and older
Enrollment: 178 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2003
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoarthritis, Hip, Osteoarthritis, Degeneration
Interventions: Leukocyte-poor platelet rich plasma; Biological
Lead sponsor: Regenerative Orthopedics and Sports Medicine; Industry
Eligibility: 30 Years to 65 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: North Bethesda, Maryland

Conditions: Femoracetabular Impingement, Pain, Postoperative
Interventions: Morphine with clonidine, Normal saline; Drug · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Knee Osteoarthritis
Interventions: Clinician-administered joint mobilization, Self-administered joint mobilization, Exercise-based physical therapy; Other
Lead sponsor: Texas Woman's University; Other
Eligibility: 45 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Allen, Texas • Plano, Texas

Conditions: Hip Osteoarthritis, Hip Injuries, Hip Sprain, Hip Strain
Interventions: The Pink Pad Hip Kit; Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 88 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Insomnia, Pain, Osteoarthritis, Knee, Osteoarthritis, Hip
Interventions: Healthy Habits, Sleep Habits; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 40 Years and older
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 3
States / cities: Galveston, Texas • Houston, Texas

Conditions: Cerebral Palsy, Hip Dysplasia, Pain, Postoperative
Interventions: Ropivacaine injection, normal saline; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: Up to 18 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 4
States / cities: Los Angeles, California • Santa Monica, California • Chicago, Illinois

Conditions: Degenerative Joint Disease
Interventions: Iconacy Hip System; Device
Lead sponsor: Iconacy Orthopedic Implants, LLC.; Industry
Eligibility: 30 Years to 80 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 2
States / cities: Louisville, Kentucky

Conditions: Osteoarthritis, Rheumatoid Arthritis, Femoral Fracture, Correction of a Functional Deformity, Avascular Necrosis
Interventions: Encore Linear™ Hip System; Device
Lead sponsor: Encore Medical, L.P.; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Vero Beach, Florida

Conditions: Arthritis, Osteo Arthritis Knee and Hip
Interventions: OACareTools+; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 99 Years
Enrollment: 205 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Patellofemoral Pain Syndrome
Interventions: Lumbopelvic manipulation; Other
Lead sponsor: Texas Woman's University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Osteoarthritis, Pain
Interventions: Placebo, Fulranumab 1 mg, Fulranumab 3 mg; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 7
States / cities: El Cajon, California • Sherman Oaks, California • Miami, Florida + 4 more

Conditions: Osteoarthritis
Interventions: single point cane; Device
Lead sponsor: Arthritis Foundation; Other
Eligibility: 60 Years to 75 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Osteoarthritis, Rheumatoid Arthritis, Post-traumatic Arthritis, Avascular Necrosis, Acute Fracture
Interventions: non-coated femoral hip stem, coated femoral hip stem; Device
Lead sponsor: DePuy Orthopaedics; Industry
Eligibility: Up to 75 Years
Enrollment: 245 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2009
U.S. locations: 1
States / cities: Warsaw, Indiana

Conditions: Dislocation, Hip
Interventions: Dual mobility implant, Traditional, Single-bearing hip implant; Device
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 412 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2035
U.S. locations: 4
States / cities: Los Angeles, California • Chicago, Illinois • New York, New York + 1 more

Conditions: Opioid Use, Pain, Femoral Acetabular Impingement, Labral Tear, Glenoid
Interventions: Control Group Regimen, Opioid reduced regimen; Other
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 170 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cerebral Palsy, Hip Dysplasia, Pain, Postoperative
Interventions: Ropivacaine injection, Bupivacaine, lidocaine, ropivacaine; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: Up to 18 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 4
States / cities: Los Angeles, California • Santa Monica, California • Chicago, Illinois

Conditions: Osteoarthritis of the Hip
Interventions: Same day discharge, Next day discharge; Procedure
Lead sponsor: Rothman Institute Orthopaedics; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • Alexandria, Virginia

Conditions: Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis, CDH
Interventions: Trinity CoC Total Hip System, Trinity Ceramic-on-Poly THR; Device
Lead sponsor: Corin; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 342 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2021
U.S. locations: 9
States / cities: Little Rock, Arkansas • Parker, Colorado • Hartford, Connecticut + 5 more

Search by objective public record fields.

Non-inferiority Trial of Oral Tranexamic Acid vs. Intravenous Tranexamic Acid in Joint Replacement Surgery

Metal on Metal Versus Ceramic on Metal Hip Replacement

Use of Knotless Suture for Closure of Total Hip and Knee Arthroplasties

Restoration of Leg Length, Offset, and Center of Rotation in Total Hip Replacement

Normative Radiographic Parameters and Growth Curve of Hips Less Than Six Weeks of Gestational Age Using Ultrasound

Addressing Patients' Expectations of Total Hip Arthroplasty in a Randomized Trial

A Comparison of PRP Treatment to the IA vs. IA and EA Environments in Patients Diagnosed With Hip Osteoarthritis

Intra-articular Morphine and Clonidine Injections for Pain Management in Hip Arthroscopy

Short-term and Intermediate-term Effects of Self-applied Joint Mobilization Versus Clinician-applied Joint Mobilization in Addition to Exercise in Patients With Knee Osteoarthritis: A Randomized Clinical Trial

Positioning for Hip Arthroscopic Surgery to Reduce Postoperative Numbness

Effectiveness of Healthy Habits for Hospitalized Older Adults to Optimize Rehabilitation

Peri-operative Use of a Pain Injection in Pediatric Patients With Cerebral Palsy

Multi-Site, Post-Market Study of the ICONACY I-Hip System

Retrospective Study of the Linear™ Hip

Osteoarthritis Care Tools for Primary Care Providers in Family Medicine and Geriatrics Clinics

Effects of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity

Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3003

Walking Aids in the Management of Hip Osteoarthritis

Clinical Study Comparing Two Implant Surface Finishes in Patients Undergoing Cementless Total Hip Replacement

Dual Mobility in "High Risk" Patients

Hip Arthroscopy Postoperative Opioid Demands

Pain Injection Versus Epidural Anesthesia for Hip Surgery in Pediatric Patients With Cerebral Palsy

A Prospective, Randomized Trial Comparing Same Day Discharge and Overnight Hospital Stay Among Total Hip Arthroplasties Done by the Direct Anterior Approach

Trinity™ BIOLOX Delta™ CoC THR Multi-center Study